February 01, 2015 7:25 AM ET


Company Overview of BioVascular, Inc.

Company Overview

BioVascular, Inc., a biotechnology company, develops and commercializes drugs and devices for the control of intimal hyperplasia associated with vascular procedures and control of risk factors in cardiovascular morbidity and mortality applications. Its products include Saratin, a polypeptide produced by recombinant means in yeast and is designed to apply during surgery to the endovascular surface; and a release formulation for cardiovascular risk reduction. The company is based in San Diego, California.

12230 El Camino Real

Suite 100

San Diego, CA 92130

United States





Key Executives for BioVascular, Inc.

Chief Executive Officer
Age: 71
Chief Medical Officer and Vice President of Clinical Research & Regulatory Affairs
Vice President of Development and Director
Vice President of Pharmaceutical Operations
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Evivrus, Inc. United States
ReCyte Therapeutics, Inc. United States
Neurona Therapeutics Inc. United States
Immunomic Therapeutics, Inc. United States
Takeda Vaccines (Montana), Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BioVascular, Inc., please visit www.biovascularinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.